News
The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...
German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...
Merck has received approval from the Food and Drug Administration for Welireg, its oral inhibitor for patients with certain rare types of neuroendocrine tumors. The company said Wednesday the ...
Merck plans to spend $895 million to expand a De Soto, Kansas, manufacturing facility for its animal health segment, the ...
Explore more
Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...
Merck Animal Health, a unit of Merck , said on Thursday it would invest $895 million to expand its manufacturing facility in ...
Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Investing.com -- Citi downgraded both AbbVie (NYSE: ABBV) and Merck (NSE: PROR) to Neutral in separate notes Wednesday, ...
Cyber attacks on companies are no longer a rarity. Volker Buß, CISO at the Merck Group, explains in the CSO interview what is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results